Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05576077
Title A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors (STARLING)
Acronym STARLING
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Turnstone Biologics, Corp.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of California Irvine RECRUITING Irvine California 92868 United States Details
Memorial Healthcare System NOT_YET_RECRUITING Hollywood Florida 33021 United States Details
University of Miami RECRUITING Miami Florida 33136 United States Details
Orlando Health RECRUITING Orlando Florida 32806 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612-9497 United States Details
University of Chicago RECRUITING Chicago Illinois 60637 United States Details
Norton Cancer Institute RECRUITING Louisville Kentucky 40202 United States Details
Providence Healthcare Research Institute RECRUITING Portland Oregon 97213 United States Details
Allegheny Research Institute RECRUITING Pittsburgh Pennsylvania 15224 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Medical College of Wisconsin RECRUITING Milwaukee Wisconsin 53226 United States Details
Princess Margaret Cancer Centre RECRUITING Toronto Ontario M5G 2C1 Canada Details
Montreal University Hospital Center RECRUITING Montréal Quebec H2X 0C1 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field